Similar articles

• [Value of ipratropium (Atrovent) in the treatment of chronic obstructive lung diseases in myasthenic patients treated with anticholinesterase agents. Apropos of a case].

  Robinet G, Leroyer C, Andre J, Dewitte JD, Clavier J. Robinet G, et al. Rev Pneumol Clin. 1989;45(4):161-3. Rev Pneumol Clin. 1989. PMID: 2533994 French.
• Ipratropium.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1987 Jul 31;29(745):71-2. Med Lett Drugs Ther. 1987. PMID: 2885730 Clinical Trial. No abstract available.
• Protective and bronchospasmolytic effect of ipratropium bromide in bronchial antigen challenge tests compared to other antiasthmatic drugs.

  Gonsior E, Schultze-Werninghaus G. Gonsior E, et al. Scand J Respir Dis Suppl. 1979;103:219-21. Scand J Respir Dis Suppl. 1979. PMID: 155302 No abstract available.
• Review of ipratropium bromide in induced bronchospasm in patients with asthma.

  Morris HG. Morris HG. Am J Med. 1986 Nov 14;81(5A):36-44. doi: 10.1016/0002-9343(86)90460-2. Am J Med. 1986. PMID: 2947459 Review.
• Intranasal ipratropium: literature abstracts and comments.

  Mygind N, Borum P. Mygind N, et al. Rhinol Suppl. 1989;9:37-44. Rhinol Suppl. 1989. PMID: 2534054 Review.